Utilizing distinct mechanisms of NK cells will be critical to have synergistic effects in combination with other cancer therapies, including chemotherapy, immune-modulating cytokines (IL-2 and IFN-γ) therapy, and immune checkpoint blockades immunotherapy. This evidence concerns the gene IFNG and cancer.